![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Press Releases
Raremark launches the Xperiome patient-powered knowledge platform to deliver new therapies faster and smarter
Raremark®, the leading online patient community in rare disease, has launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new...
News
Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, announced the success of its complimentary COVID-19...
News
Abzena appoints Matthew LeClair as SVP and Site Head of San Diego Operations
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of...
News
Biocair Expands US Presence And Capacity
With the expansion of two of Biocair’s North American facilities, the company’s offerings in the US have increased substantially.
The Philadelphia office has doubled...
News
Pharmapack Moves to May 2021
Pharmapack Europe, organised by Informa Markets, moves to May 2021 (19-20) to provide attendees, exhibitors and the pharma packaging community the best season and...
Packaging & Labelling
Sharp has achieved landfill-free status across its global facility network
Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has achieved landfill-free status across its global facility...
Drug Research
Daiichi Sankyo and AstraZeneca Enter New Global Development and Commercialization Collaboration for Daiichi Sankyo’s ADC DS-1062
Daiichi Sankyo Company, Limited announced that it has entered into a global development and commercialization agreement with AstraZeneca for Daiichi Sankyo’s DS-1062, a TROP2...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
